While outcomes from HCV-positive and HCV-negative donor kidneys are comparable in the short term, questions remain about the clinical consequences of preexisting HCV-related kidney injury, which may go undetected at the time of organ procurement.1-5 We previously reported a case of successful kidney transplantation from an HCV-positive donor with mesangial proliferative glomerulonephritis (GN) into an HCV-negative recipient with reversal of HCV-associated histologic changes after antiviral treatment.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: